# Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera

> **NCT01038856** · PHASE2 · TERMINATED · sponsor: **University of Oklahoma** · enrollment: 5 (actual)

## Conditions studied

- Polycythemia Vera

## Interventions

- **DRUG:** Erlotinib

## Key facts

- **NCT ID:** NCT01038856
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-12
- **Primary completion:** 2012-12
- **Final completion:** 2014-02
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** The study was terminated by the sponsor
- **Last updated:** 2020-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01038856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01038856, "Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01038856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*